BIOMAT Database Logo BIOMAT Database Logo

GR231118 (1229U91) and other analogues of the C-terminus of neuropeptide Y are potent neuropeptide Y Y1 receptor antagonists and neuropeptide Y Y4 receptor agonists. 1998

E M Parker, and C K Babij, and A Balasubramaniam, and R E Burrier, and M Guzzi, and F Hamud, and G Mukhopadhyay, and M S Rudinski, and Z Tao, and M Tice, and L Xia, and D E Mullins, and B G Salisbury
Department of Central Nervous System and Cardiovascular Research, Schering-Plough Research Institute, Kenilworth, NJ 07033-0539, USA. eric.parker@spcorp.com

GR231118, BW1911U90, Bis(31/31')[[Cys31, Trp32, Nva34] neuropeptide Y(31-36)] (T-190) and [Trp-Arg-Nva-Arg-Tyr]2-NH2 (T-241) are peptide analogs of the C-terminus of neuropeptide Y that have recently been shown to be antagonists of the neuropeptide Y Y1 receptor. In this study, the activity of these peptides at each of the cloned neuropeptide Y receptor subtypes is determined in radioligand binding assays and in functional assays (inhibition of forskolin-stimulated cAMP formation). GR231118 is a potent antagonist at the human and rat neuropeptide Y Y1 receptors (pA2 = 10.5 and 10.0, respectively; pKi = 10.2 and 10.4, respectively), a potent agonist at the human neuropeptide Y Y4 receptor (pEC50 = 8.6; pKi = 9.6) and a weak agonist at the human and rat neuropeptide Y Y2 and Y5 receptors. GR231118 also has high affinity for the mouse neuropeptide Y Y6 receptor (pKi = 8.8). Therefore, GR231118 is a relatively selective neuropeptide Y Y1 receptor antagonist, but has appreciable activity at the neuropeptide Y Y4 and Y6 receptors as well. BW1911U90, T-190 and T-241 are moderately potent neuropeptide Y Y1 receptor antagonists (pA2 = 7.1, 5.8 and 6.5, respectively; pKi = 8.3, 6.5 and 6.8, respectively) and neuropeptide Y Y4 receptor agonists (pEC50 = 6.8, 6.3 and 6.6, respectively; pKi; 8.3, 7.7 and 8.3, respectively). These data suggest that the C-terminus of neuropeptide Y and related peptides is sufficient for activation of the neuropeptide Y Y4 receptor, but is not sufficient for activation of the neuropeptide Y Y1 receptor. Because BW1911U90, T-190 and T-241 are significantly less potent at the cloned human neuropeptide Y Y1 receptor than at the neuropeptide Y receptor in human erythroleukemia cells, these cells may express a novel neuropeptide Y receptor with high affinity for these peptides.

UI MeSH Term Description Entries
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D009478 Neuropeptide Y A 36-amino acid peptide present in many organs and in many sympathetic noradrenergic neurons. It has vasoconstrictor and natriuretic activity and regulates local blood flow, glandular secretion, and smooth muscle activity. The peptide also stimulates feeding and drinking behavior and influences secretion of pituitary hormones. Neuropeptide Y-Like Immunoreactive Peptide,Neuropeptide Tyrosine,Neuropeptide Y Like Immunoreactive Peptide,Tyrosine, Neuropeptide
D009842 Oligopeptides Peptides composed of between two and twelve amino acids. Oligopeptide
D010456 Peptides, Cyclic Peptides whose amino acid residues are linked together forming a circular chain. Some of them are ANTI-INFECTIVE AGENTS; some are biosynthesized non-ribosomally (PEPTIDE BIOSYNTHESIS, NON-RIBOSOMAL). Circular Peptide,Cyclic Peptide,Cyclic Peptides,Cyclopeptide,Orbitide,Circular Peptides,Cyclopeptides,Orbitides,Peptide, Circular,Peptide, Cyclic,Peptides, Circular
D011869 Radioligand Assay Quantitative determination of receptor (binding) proteins in body fluids or tissue using radioactively labeled binding reagents (e.g., antibodies, intracellular receptors, plasma binders). Protein-Binding Radioassay,Radioreceptor Assay,Assay, Radioligand,Assay, Radioreceptor,Assays, Radioligand,Assays, Radioreceptor,Protein Binding Radioassay,Protein-Binding Radioassays,Radioassay, Protein-Binding,Radioassays, Protein-Binding,Radioligand Assays,Radioreceptor Assays
D006224 Cricetinae A subfamily in the family MURIDAE, comprising the hamsters. Four of the more common genera are Cricetus, CRICETULUS; MESOCRICETUS; and PHODOPUS. Cricetus,Hamsters,Hamster
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000595 Amino Acid Sequence The order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of proteins. It is of fundamental importance in determining PROTEIN CONFORMATION. Protein Structure, Primary,Amino Acid Sequences,Sequence, Amino Acid,Sequences, Amino Acid,Primary Protein Structure,Primary Protein Structures,Protein Structures, Primary,Structure, Primary Protein,Structures, Primary Protein
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D014162 Transfection The uptake of naked or purified DNA by CELLS, usually meaning the process as it occurs in eukaryotic cells. It is analogous to bacterial transformation (TRANSFORMATION, BACTERIAL) and both are routinely employed in GENE TRANSFER TECHNIQUES. Transfections

Related Publications

E M Parker, and C K Babij, and A Balasubramaniam, and R E Burrier, and M Guzzi, and F Hamud, and G Mukhopadhyay, and M S Rudinski, and Z Tao, and M Tice, and L Xia, and D E Mullins, and B G Salisbury
The neuropeptide Y Y1 antagonist, 1229U91, a potent agonist for the human pancreatic polypeptide-preferring (NPY Y4) receptor.
January 1998, Peptides,
E M Parker, and C K Babij, and A Balasubramaniam, and R E Burrier, and M Guzzi, and F Hamud, and G Mukhopadhyay, and M S Rudinski, and Z Tao, and M Tice, and L Xia, and D E Mullins, and B G Salisbury
Potent neuropeptide Y Y1 receptor antagonist, 1229U91: blockade of neuropeptide Y-induced and physiological food intake.
August 1996, Endocrinology,
E M Parker, and C K Babij, and A Balasubramaniam, and R E Burrier, and M Guzzi, and F Hamud, and G Mukhopadhyay, and M S Rudinski, and Z Tao, and M Tice, and L Xia, and D E Mullins, and B G Salisbury
Stimulation of the gonadotropic axis by the neuropeptide Y receptor Y1 antagonist/Y4 agonist 1229U91 in the male rat.
January 2000, Neuroendocrinology,
E M Parker, and C K Babij, and A Balasubramaniam, and R E Burrier, and M Guzzi, and F Hamud, and G Mukhopadhyay, and M S Rudinski, and Z Tao, and M Tice, and L Xia, and D E Mullins, and B G Salisbury
Pharmacological characterization of (125)I-1229U91 binding to Y1 and Y4 neuropeptide Y/Peptide YY receptors.
April 2000, The Journal of pharmacology and experimental therapeutics,
E M Parker, and C K Babij, and A Balasubramaniam, and R E Burrier, and M Guzzi, and F Hamud, and G Mukhopadhyay, and M S Rudinski, and Z Tao, and M Tice, and L Xia, and D E Mullins, and B G Salisbury
Dimeric argininamide-type neuropeptide Y receptor antagonists: chiral discrimination between Y1 and Y4 receptors.
November 2013, Bioorganic & medicinal chemistry,
E M Parker, and C K Babij, and A Balasubramaniam, and R E Burrier, and M Guzzi, and F Hamud, and G Mukhopadhyay, and M S Rudinski, and Z Tao, and M Tice, and L Xia, and D E Mullins, and B G Salisbury
Different binding sites for the neuropeptide Y Y1 antagonists 1229U91 and J-104870 on human Y1 receptors.
March 2001, Peptides,
E M Parker, and C K Babij, and A Balasubramaniam, and R E Burrier, and M Guzzi, and F Hamud, and G Mukhopadhyay, and M S Rudinski, and Z Tao, and M Tice, and L Xia, and D E Mullins, and B G Salisbury
Role of the C terminus in neuropeptide Y Y1 receptor desensitization and internalization.
March 2005, Molecular pharmacology,
E M Parker, and C K Babij, and A Balasubramaniam, and R E Burrier, and M Guzzi, and F Hamud, and G Mukhopadhyay, and M S Rudinski, and Z Tao, and M Tice, and L Xia, and D E Mullins, and B G Salisbury
1,3-Disubstituted benzazepines as novel, potent, selective neuropeptide Y Y1 receptor antagonists.
July 1999, Journal of medicinal chemistry,
E M Parker, and C K Babij, and A Balasubramaniam, and R E Burrier, and M Guzzi, and F Hamud, and G Mukhopadhyay, and M S Rudinski, and Z Tao, and M Tice, and L Xia, and D E Mullins, and B G Salisbury
Synthetic routes to the Neuropeptide Y Y1 receptor antagonist 1229U91 and related analogues for SAR studies and cell-based imaging.
May 2014, Organic & biomolecular chemistry,
E M Parker, and C K Babij, and A Balasubramaniam, and R E Burrier, and M Guzzi, and F Hamud, and G Mukhopadhyay, and M S Rudinski, and Z Tao, and M Tice, and L Xia, and D E Mullins, and B G Salisbury
Pharmacological evaluation of 1229U91, a novel high-affinity and selective neuropeptide Y-Y1 receptor antagonist.
December 1995, The Journal of pharmacology and experimental therapeutics,
Copied contents to your clipboard!